News - Appointments

Scancell Holdings Plc, which is developing vaccines against cancer as well as Covid-19, has appointed Gillies O’Bryan-Tear as chief medical officer and Robert Miller as medical director.

Suba Krishnan, an oncology expert, is to join Mereo BioPharma Group Plc on 7 December as head of clinical development where she will help advance etigilimab, a prospective treatment for advanced solid tumours.

Torsten Hoffmann, inventor of the anti-emetic medicine Akynzeo, has been named chief scientific officer at Oryzon Genomics SA which is developing epigenetic-based therapeutics.

Silence Therapeutics Plc has promoted Marie Wikström Lindholm to it

Mogrify Ltd is expanding its scientific advisory board with the appointment of three academic experts in the field of cell therapy.

Stephen Squinto, an executive partner at OrbiMed Advisors LLC, has joined Genenta Science Srl as chairman of the company’s board of directors. Based in Milan, Italy, Genenta is developing a gene therapy for cancer.

France-based Polyplus-transfection SA has appointed Mario Philips as chief executive officer to lead its service business for the gene and cell therapy industry.

Belgium-based ExeVir Bio BV has appointed Michel Kazatchkine and Stef Heylen to its board of directors. The company is developing nanobody therapies providing broad protection against viral infections, including a lead candidate targeting for coronaviruses.

Denmark-based UNION therapeutics A/S has appointed Kim Kjoeller as chief executive, effective 1 January 2021, and Günter Ditzinger as chief technology officer.

Stewart Kay has joined UK-based Adaptate Biotherapeutics Ltd in the new role of chief business officer (CBO).